An analysis of the gross behavioural changes induced by tetraethylammonium and a comparison with other substances affecting the autonomic and central nervous system after inraventricular inejctions to conscious cats.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology; D001337:Autonomic Agents / Q000494:pharmacology*; D001522:Behavior, Animal / Q000187:drug effects*; D002118:Calcium / Q000494:pharmacology; D002415:Cats; D002552:Cerebral Ventricles; D004305:Dose-Response Relationship, Drug; D005260:Female; D005730:Ganglionic Blockers / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D006982:Hypertonic Solutions; D007267:Injections; D008274:Magnesium / Q000494:pharmacology; D008297:Male; D009466:Neuromuscular Blocking Agents / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology; D000644:Quaternary Ammonium Compounds / Q000008:administration & dosage / Q000494:pharmacology*; D012702:Serotonin Antagonists; D014508:Urea / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000927:Anticonvulsants; D001337:Autonomic Agents; D005730:Ganglionic Blockers; D006634:Histamine H1 Antagonists; D006982:Hypertonic Solutions; D009466:Neuromuscular Blocking Agents; D010276:Parasympatholytics; D000644:Quaternary Ammonium Compounds; D012702:Serotonin Antagonists; D014508:Urea; D008274:Magnesium; D005947:Glucose; D002118:Calcium